Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Frontiers in Bioinformatics|November 3, 2025
CoMPHI: a novel composite machine learning approach utilizing multiple feature representation to predict hosts of bacteriophagesShreyashi Bodaka, Narasaiah KolliputiAmerican Journal of Respiratory Cell and Molecular Biology|September 9, 2008
IL-6 cytoprotection in hyperoxic acute lung injury occurs via suppressor of cytokine signaling-1-induced apoptosis signal-regulating kinase-1 degradationNarasaiah Kolliputi, Aaron B WaxmanAmerican Journal of Respiratory Cell and Molecular Biology|January 27, 2009
IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusinsAaron B Waxman, Narasaiah KolliputiAmerican Journal of Physiology. Lung Cellular and Molecular Physiology|April 21, 2009
IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylationNarasaiah Kolliputi, Aaron B WaxmanCell Biochemistry and Biophysics|May 1, 2023
Nuclear Export Inhibitors Selinexor (KPT-330) and Eltanexor (KPT-8602) Provide a Novel Therapy to Reduce Tumor Growth by Induction of PANoptosisSamuel Camilli, Richard Lockey, Narasaiah KolliputiAmerican Journal of Physiology. Cell Physiology|January 27, 2021
Soluble ACE2 as a potential therapy for COVID-19Sudarshan Krishnamurthy, Richard F Lockey, Narasaiah KolliputiBiomolecules|August 26, 2022
Can PPAR <i>γ</i> Keep Cadmium in Check?Caila Robinson, Richard F Lockey, Narasaiah KolliputiThe Journal of Allergy and Clinical Immunology. Global|August 22, 2024
PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosisDalan Smallwood, Richard F Lockey, Narasaiah KolliputiCell Biochemistry and Biophysics|October 2, 2023
Pyroptosis Inhibition in Disease Treatment: Opportunities and ChallengesNavya Bandharam, Richard F Lockey, Narasaiah KolliputiJournal of Cell Communication and Signaling|September 8, 2020
Coronavirus: a shift in focus away from IFN response and towards other inflammatory targetsAkshaya Thoutam, Mason Breitzig, Richard Lockey, et al.Pageof 9